3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
22
Rectal Neoplasms
10
Colonic Neoplasms
10
Stomach Neoplasms
8
Adenocarcinoma Of Esophagus
8
Pancreatic Neoplasms
7
Esophageal Neoplasms
7
Adenocarcinoma
6
Lymphoma, Large B-Cell, Diffuse
5
Cholangiocarcinoma
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Neoplasm Metastasis
4
Neoplasms
3
Gallbladder Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Carcinoma
3
Biliary Tract Neoplasms
3
Ovarian Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Lung Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Advanced Solid Tumors
2
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Solid Tumors
1
Small Bowel Adenocarcinoma
1
Recurrence
1
Interventions
pembrolizumab
14
Cisplatin
8
Carboplatin
4
dostarlimab
3
Cetuximab
3
abemaciclib
2
Surgical Procedures, Operative
2
Radiotherapy, Intensity-Modulated
2
Paclitaxel
2
Nivolumab
2
Fulvestrant
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
tislelizumab
1
ribociclib
1
repotrectinib
1
patritumab deruxtecan
1
palbociclib
1
osimertinib
1
olaparib
1
niraparib
1
nimotuzumab
1
merphos
1
ibrutinib
1
fludarabine
1
exemestane
1
entrectinib
1
carbohydrate-deficient transferrin
1
brodalumab
1
avelumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Oxaliplatin
×
30 days
×
Clear all
No trials found.